NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

The National Institute of Allergy and Infectious Diseases (NIAID) has announced a funding opportunity for Resource-Related Research Projects (R24), with a specific focus on non-clinical trial studies. This grant invite is open to researches planning initiatives that could provide substantial aid to currently funded high-priority projects, specifically those requiring additional support and coordination in specified areas.

The opportunity also permits use of the grant for the development of new resources and tools beneficial to the wider scientific community associated with NIAID, although such a scenario is considered rare and will only be viable if no alternative support mechanisms are available from the institute.

Applications are encouraged from those whose proposed resources align closely with the strategic interests of NIAID. These include studies on the biology, pathogenesis, and host response to microbes (including HIV), the workings of the immune system in health and disease, and translational research aiming to develop vaccines, therapeutics, and diagnostic tools to prevent and treat infectious, immune-mediated, and allergic diseases.

This opportunity is not expected to be frequently available and is reserved for cases where it is seen as the most suitable form of NIAID support.